Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer;Radiotherapie hyperfractionnee acceleree alternee avec une chimiotherapie dans le cancer du sein inflammatoire non metastatique

Cancer/Radiotherapie

Volumn 4, Issue 4, 2000, Pages 265-273

  Hasbini, A ^a   Le Pechoux C ^a   Roche, B ^a   Pignol, J P ^a   Zelek, L ^a   Abdulkarim, B ^a   Arriagada, R ^b   Guinebretiere J M ^a   Tardivon, A ^a   Spielmann, M ^a   Habrand, J L ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Instituto de Radiomedicina Santiago   (Chile)

Author keywords

Chemotherapy; Hyperfractionated accelerated radiotherapy; Inflammatory breast carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; VINCRISTINE; CAF PROTOCOL; CMFDV PROTOCOL; EPIRUBICIN; FEC PROTOCOL;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RECURRENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; ADENOCARCINOMA; BREAST TUMOR; CLINICAL TRIAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOSE FRACTIONATION; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0033855420     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(00)80004-9     Document Type: Article

References (38)

1. The value of adjunctive radiotherapy when chemotherapy is the major curative method
2. Alternating radiotherapy and chemotherapy schedules in small-cell lung cancer, limited disease
3. Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer
4. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination
5. Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: Complete response predicts outcome and allows for breast conservation
6. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy
7. Results of treating stage III carcinoma of the breast by primary radiation therapy
8. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation
9. Inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program of the national cancer institute, 1975-1992
10. Le cancer du sein inflammatoire
11. The centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients
12. Inflammatory breast carcinoma treated by radical radiotherapy
13. Treatment of malignant breast tumors
14. Prognostic factors in inflammatory breast cancer. Univariate and multivariate analysis
15. Inflammatory carcinoma of the breast: Treatment results on 107 patients
16. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammmatory breast carcinoma
17. Dose-response relationship of epirubicin-based first line chemotherapy for advanced breast cancer: A prospective randomized trial
18. Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environnement units: A prospective randomized study
19. Treatment of locally advanced and inflammatory breast cancer
20. The importance of dose intensity in chemotherapy of metastatic breast cancer
21. Inflammatory breast cancer: A review
22. Inflammatory carcinoma of the breast: Results of a combined-modality approach - MD Anderson Cancer Center experience
23. Diagnosis and management of inflammatory breast cancer
24. Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast
25. Evaluation of survival data and two new rank order arising in its consideration
26. Cell kinetics and hormonal receptor status in inflammatory breast carcinoma, comparison with locally advanced disease
27. Therapeutic strategies inflammatory breast carcinoma based on prognostic factors
28. Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the institut Gustave-Roussy
29. Le traitement du cancer du sein inflammatoire. Associations chimiotherapie-radiotherapie. A propos de 270 femmes traitees a l'institut Gustave-Roussy
30. Inflammatory symptoms in breast cancer
31. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy
32. Multimodal treatment for inflammatory breast cancer
33. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically agressive non Hodgkin's lymphomas
34. Combined-modality treatment of inflammatory breast carcinoma twenty years of experience at M. D. Anderson Cancer Center
35. Combined chemotherapy, radiotherapy and surgery in inflammatory breast carcinoma
36. The hazard of accelerated tumor clonogen repopulation during radiotherapy